Multiple Sclerosis, Myelin back to the drawing board with Biogen’s Myelin repair drug….CRAP! June 8, 2016 Dave Anti-LINGO – This would have been a game changer 🙁 http://www.investors.com/news/technology/biogen-loses-big-ms-gamble-as-anti-lingo-fails-clinical-trial/